BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 16107833)

  • 1. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.
    Capobianchi MR; Abbate I; Cappiello G; Solmone M
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S22-4. PubMed ID: 12655342
    [No Abstract]   [Full Text] [Related]  

  • 3. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Bode JG; Brenndörfer ED; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):254-65. PubMed ID: 17467654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
    Thimme R; Lohmann V; Weber F
    Antiviral Res; 2006 Mar; 69(3):129-41. PubMed ID: 16413618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses.
    Suthar MS; Gale M; Owen DM
    Cell Microbiol; 2009 Jun; 11(6):880-8. PubMed ID: 19341437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of hepatitis C virus infection.
    Camps J; Córdoba J; Esteban JI
    Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
    Moorman JP; Joo M; Hahn YS
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future options for the management of hepatitis C.
    Davis GL; Nelson DR; Reyes GR
    Semin Liver Dis; 1999; 19 Suppl 1():103-12. PubMed ID: 10349698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models to study the immunobiology of hepatitis C virus.
    Jo J; Lohmann V; Bartenschlager R; Thimme R
    J Gen Virol; 2011 Mar; 92(Pt 3):477-93. PubMed ID: 21148278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell response in hepatitis C virus infection.
    Neumann-Haefelin C; Blum HE; Chisari FV; Thimme R
    J Clin Virol; 2005 Feb; 32(2):75-85. PubMed ID: 15653409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.